COVID-19

Combatting COVID-19: 21 Innovative Efforts

Combatting COVID-19: 21 Innovative Efforts

We’re not sharing this information to scare, but instead to inform on the challenges the healthcare industry is facing. With that in mind, below we report on 21 innovative efforts from leading and emerging players in the biotech industry to combat the COVID-19 pandemic.

read more
Brett Averso on the AI Podcast in 26.1 Minutes

Brett Averso on the AI Podcast in 26.1 Minutes

Our very own Brett Averso (CTO, EVQLV) was welcomed on the AI Podcast in 26.1 Minutes with hosts Brian Ray and Don Sheu. They discussed our work on COVID-19 with ImmunoPrecise, the benefits of a computational approach to antibody research and drug discovery, our progress as a company and a host of other topics.

read more
EVQLV Submits First Panel of Optimized Antibody Sequences

EVQLV Submits First Panel of Optimized Antibody Sequences

EVQLV, has submitted their first panel of candidate therapeutic antibody sequences, comprised of DNA sequences encoding for potentially therapeutic antibodies against the new coronavirus, SARS-CoV-2. These DNA sequences were generated using computational antibody design, a method which combines mathematics, statistics, and computer science to identify high-affinity antibodies.

read more

Pin It on Pinterest